GUAIFENESIN EXTENDE

The Defense Logistics Agency awarded a delivery order under the base contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, with CAGE code 1UNB0, for the procurement of 25.000 boxes of GUAIFENESIN EXTENDE (NSN 6505017249533) at a unit price of $5.5400, resulting in a total contract value of $138.50. The award was issued on July 20, 2026, under solicitation SPE2DP26F7786, and delivery is scheduled for August 4, 2026, with FOB destination terms placing all shipping responsibility and costs on the contractor. The delivery must be made to Fort Bragg, North Carolina, with precise marking requirements including the Traceable Control Number and National Drug Code labels, while prohibiting parcel post and mandating the fastest traceable shipping method. The contract incorporates FAR 52.222-50, requiring compliance with anti-trafficking regulations, and DFARS 252.232-7003, which governs electronic invoicing through the Wide Area WorkFlow system. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, under accounting string BX: 97X4930 5CBX 001 2620 S33189, with net 30 payment terms. DMS Pharmaceutical Group Inc. is recognized as a small business under the HUSBIDEN SIZE SMALL BUSINESS PROGRAM, and the contract includes no option periods or quantity variances. Acceptance occurs at the destination by the government, and no specific MIL-STD packaging standards are cited, although marking and labeling must follow the provided government directives. The administering office is located in Philadelphia, Pennsylvania, with Shairy M. Cartagena designated as the local point of contact for administrative matters. No additional special requirements, evaluation factors, or socioeconomic certifications beyond small business status are documented.